Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: Multi-center, open-label randomized study of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryopreserved cord blood progenitor cells in patients with hematologic malignancies (2603.00)

 


Multi-center, open-label randomized study of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryopreserved cord blood progenitor cells in patients with hematologic malignancies (2603.00)


Trial Focus

Leukemia/Myelodysplasia

Objective

         This is a clinical trial of single or double myeloablative cord blood transplantation with or without infusion of off-the-shelf ex vivo expanded cryopreserved cord blood progenitor cells which will be administered intravenously or by infusion.

IRB Protocol #

12-1501

Trial Status

OPEN

Principle Investigator

JONATHAN GUTMAN

Sponsor

Fred Hutchinson Cancer Research Center

Contact

DEREK SCHATZ at (720)848-0628 or DEREK.SCHATZ@UCDENVER.EDU

Location

University of Colorado Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : You will be on this study for about 2 years. // Eligibility include but are not limited to between 18 and 45 years old with leukemia or MDSEligibility include but are not limited to between 18 and 45 years old with leukemia or MDS